Literature DB >> 34262099

MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells.

Bieke Decaesteker1,2, Winnok H De Vos3, Sofia Zanotti3,1,2, Suzanne Vanhauwaert1,2, Christophe Van Neste1,2, Volodimir Olexiouk1,2, Jolien Van Laere1,2, Marlies Verschuuren3, Joni Van der Meulen1,2,4, Liselot M Mus1,2,5, Kaat Durinck1,2, Laurentijn Tilleman2,6, Dieter Deforce2,6, Filip Van Nieuwerburgh2,6, Michael D Hogarty7,8, Frank Speleman9,10.   

Abstract

MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of immortalized human retina pigment epithelial cells with inducible MYCN activation. Gene signatures associated with elevated MYC/MYCN activity were induced after 24 h of MYCN activation, which attenuated but sustained at later time points. Unexpectedly, MYCN activation was accompanied by reduced cell growth. Gene set enrichment analysis revealed a senescence-like signature with strong induction of p53 and p21 but in the absence of canonical hallmarks of senescence such as β-galactosidase positivity, suggesting incomplete cell fate commitment. When scrutinizing the putative drivers of this growth attenuation, differential gene expression analysis identified several regulators of nucleolar stress. This process was also reflected by phenotypic correlates such as cytoplasmic granule accrual and nucleolar coalescence. Hence, we propose that the induction of MYCN congests the translational machinery, causing nucleolar stress and driving cells into a transient pre-senescent state. Our findings shed new light on the early events induced by MYCN activation and may help unravelling which factors are required for cells to tolerate unscheduled MYCN overexpression during early malignant transformation.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34262099     DOI: 10.1038/s41598-021-93863-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

1.  RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma.

Authors:  Kristina A Cole; Jonathan Huggins; Michael Laquaglia; Chase E Hulderman; Mike R Russell; Kristopher Bosse; Sharon J Diskin; Edward F Attiyeh; Rachel Sennett; Geoffrey Norris; Marci Laudenslager; Andrew C Wood; Patrick A Mayes; Jayanti Jagannathan; Cynthia Winter; Yael P Mosse; John M Maris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-02       Impact factor: 11.205

Review 2.  Target gene-independent functions of MYC oncoproteins.

Authors:  Apoorva Baluapuri; Elmar Wolf; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-18       Impact factor: 94.444

3.  ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Authors:  Qun Wang; George Hii; Suzanne Shusterman; Yael Mosse; Cynthia L Winter; Chun Guo; Huaqing Zhao; Eric Rappaport; Michael D Hogarty; John M Maris
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

Review 4.  p21: A Two-Faced Genome Guardian.

Authors:  Alexandros G Georgakilas; Olga A Martin; William M Bonner
Journal:  Trends Mol Med       Date:  2017-03-07       Impact factor: 11.951

Review 5.  The Expanding World of N-MYC-Driven Tumors.

Authors:  David S Rickman; Johannes H Schulte; Martin Eilers
Journal:  Cancer Discov       Date:  2018-01-22       Impact factor: 39.397

Review 6.  Medulloblastomics revisited: biological and clinical insights from thousands of patients.

Authors:  Volker Hovestadt; Olivier Ayrault; Fredrik J Swartling; Giles W Robinson; Stefan M Pfister; Paul A Northcott
Journal:  Nat Rev Cancer       Date:  2019-12-09       Impact factor: 69.800

7.  Dissecting transcriptional amplification by MYC.

Authors:  Zuqin Nie; Chunhua Guo; Subhendu K Das; Carson C Chow; Eric Batchelor; S Stoney Simons; David Levens
Journal:  Elife       Date:  2020-07-27       Impact factor: 8.140

8.  Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.

Authors:  Frank Westermann; Daniel Muth; Axel Benner; Tobias Bauer; Kai-Oliver Henrich; André Oberthuer; Benedikt Brors; Tim Beissbarth; Jo Vandesompele; Filip Pattyn; Barbara Hero; Rainer König; Matthias Fischer; Manfred Schwab
Journal:  Genome Biol       Date:  2008-10-13       Impact factor: 13.583

9.  MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma.

Authors:  Ganna Oliynyk; María Victoria Ruiz-Pérez; Lourdes Sainero-Alcolado; Johanna Dzieran; Hanna Zirath; Héctor Gallart-Ayala; Craig E Wheelock; Henrik J Johansson; Roland Nilsson; Janne Lehtiö; Marie Arsenian-Henriksson
Journal:  iScience       Date:  2019-10-11

10.  Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.

Authors:  Samuel W Brady; Yanling Liu; Xiaotu Ma; Alexander M Gout; Kohei Hagiwara; Xin Zhou; Jian Wang; Michael Macias; Xiaolong Chen; John Easton; Heather L Mulder; Michael Rusch; Lu Wang; Joy Nakitandwe; Shaohua Lei; Eric M Davis; Arlene Naranjo; Cheng Cheng; John M Maris; James R Downing; Nai-Kong V Cheung; Michael D Hogarty; Michael A Dyer; Jinghui Zhang
Journal:  Nat Commun       Date:  2020-10-14       Impact factor: 14.919

View more
  4 in total

Review 1.  Regulation of 3D Organization and Its Role in Cancer Biology.

Authors:  Anghui Peng; Wang Peng; Ruiqi Wang; Hao Zhao; Xinyang Yu; Yihao Sun
Journal:  Front Cell Dev Biol       Date:  2022-06-08

Review 2.  Cellular senescence in neuroblastoma.

Authors:  Sofia Zanotti; Bieke Decaesteker; Suzanne Vanhauwaert; Bram De Wilde; Winnok H De Vos; Frank Speleman
Journal:  Br J Cancer       Date:  2022-02-23       Impact factor: 9.075

Review 3.  Nucleolus and Nucleolar Stress: From Cell Fate Decision to Disease Development.

Authors:  Lu Hua; Daliang Yan; Chunhua Wan; Baoying Hu
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

4.  Fractionated irradiation of MCF7 breast cancer cells rewires a gene regulatory circuit towards a treatment-resistant stemness phenotype.

Authors:  Auchi Inalegwu; Bart Cuypers; Jürgen Claesen; Ann Janssen; Amelie Coolkens; Sarah Baatout; Kris Laukens; Winnok H De Vos; Roel Quintens
Journal:  Mol Oncol       Date:  2022-06-15       Impact factor: 7.449

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.